FIELD: biomedicine and nanomedicine.
SUBSTANCE: invention relates to conjugates of a nanoparticle with a functional molecule for medical use, characterized by the following: on the surface of a water-compatible stable nanoparticle with magnetic properties consisting of gold and magnetite Fe3O4, a stabilizing compound with a carboxyl group is immobilized, which is a carbene ligand of formula (I), where R1 and R2 are independently selected from the group consisting of COOR5 or COOR6; R3 and R4 are independently selected from the group consisting of H, C1-C6 alkyl, C3-C7 cycloalkyl, C1-C6 alkyloxy and halogen; R5 and R6 are independently selected from the group consisting of H; C1-C6 alkyl; C3-C7 cycloalkyl; C1-C6 alkyloxy and halogen. The proposed conjugate retains colloidal stability after drying and has the ability to resuspend in water, in a buffer aqueous solution or in a biological sample. Nanoparticle sizes range from 5 to 100 nm. The specified nanoparticle is connected to the functional molecule directly or using a linker having the general formula СONH(CH2)m Y, where Y=COOH, NH2, SH, CONH2, OH, CHO, CO-PEG-OH or CO- PEI-NH2, m can take values from 3 to 12, the functional molecule is selected from the group consisting of a therapeutic drug or a diagnostic substance. In particular, the functional group may be a small molecule, coumarin, photosensitizer, protein, carbohydrate, lipid, DNA, transporter, template, ribosomal or microRNA, synthetic nucleic acid analogs, synthetic polymer polyethylene glycol or polyethyleneimine, a pharmacologically active compound. The invention also relates to a method of using the specified conjugate in magnetic resonance imaging, spectrophotometric analysis, enzyme-linked immunosorbent assay, immunochromatographic analysis, as a contrast for computed tomography, for detection of target molecules, for delivery of target molecules into living cells and organisms, as an agent for radiotherapy, for targeted delivery of a therapeutic drug into cells.
EFFECT: increase of the colloidal stability of conjugates of magnetite-gold nanoparticles (Fe3O4@AuNP@NHC) with functional molecules to external physical and chemical exposure, including in biological environments, as well as facilitating the process of storage and transportation due to the ability of these conjugates to maintain colloidal stability upon drying, ensuring the possibility of delivering diagnostic and medicinal substances to target cells.
77 cl, 10 dwg, 29 ex
Title | Year | Author | Number |
---|---|---|---|
NANOPARTICLE OF GOLD-MAGNETITE COMPOSITION, METHOD OF PRODUCING NANOPARTICLE (VERSIONS), CONJUGATE BASED ON IT (VERSIONS), METHOD OF PRODUCING CONJUGATE AND TEST KIT | 2023 |
|
RU2814660C1 |
NANOAGENTS FOR SCREENING PATHOGENIC STRAINS OF MULTIDRUG-RESISTANT BACTERIA AND METHOD OF PREPARATION | 2022 |
|
RU2804488C1 |
METHOD OF DETECTING PATHOGENIC BACTERIA STRAINS | 2022 |
|
RU2802435C1 |
CARBENE LIGAND AND ULTRASTABLE GOLD NANOPARTICLES ON ITS BASIS | 2021 |
|
RU2792581C1 |
DOXORUBICIN-GOLD NANOCONJUGATES WITH DIRECTIONAL INFLUENCE FOR TUMOR THERAPY | 2018 |
|
RU2773707C2 |
IONISABLE CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY | 2023 |
|
RU2823298C1 |
RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF | 2015 |
|
RU2682335C2 |
METHOD FOR PREPARING PHARMACEUTICALLY ACCEPTABLE DOSAGE FORMS AND USING THEM IN COMBINED CHEMOTHERAPY AND PHOTODYNAMIC THERAPY OF MALIGNANT NEOPLASMS | 2023 |
|
RU2822629C1 |
MEDICINAL PRODUCT FOR TREATMENT OF BREAST CANCER | 2017 |
|
RU2657545C1 |
NEW OLIGONUCLEOTIDES CONJUGATES AND USE THEREOF | 2012 |
|
RU2599449C1 |
Authors
Dates
2024-01-10—Published
2023-04-10—Filed